DailyStocks Stock Article Search

https://seekingalpha.com/news/4050285-cvrx-stock-gains-after-fda-label-update-barostim?source=feed_sector_healthcare Dec 26, 2023 - CVRx (CVRX) receives FDA approval for expanded labeling of its flagship product Barostim, that could lead to a higher market opportunity for the device. Read more here. 0

https://www.zacks.com/stock/news/2201594/wall-street-analysts-see-a-25-31-upside-in-dole-dole-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2201594 Dec 22, 2023 - The average of price targets set by Wall Street analysts indicates a potential upside of 25.3% in Dole (DOLE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0

https://www.zacks.com/stock/news/2201596/wall-street-analysts-see-a-100-upside-in-quipt-home-medical-corp-qipt-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2201596 Dec 22, 2023 - The consensus price target hints at a 100% upside potential for Quipt Home Medical Corp. (QIPT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 0

https://www.fool.com/investing/2023/12/22/virgin-galactic-charts-path-to-survival/?source=iedfolrf0000001 Dec 22, 2023 - Could a rising stock price fix Virgin Galactic's biggest problem? 0

https://seekingalpha.com/news/4049484-agri-groups-urge-reopening-of-key-border-crossings-in-texas-railroad-operators-see-impact?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news Dec 21, 2023 - U.S. agricultural groups urge government to reopen two key rail crossings on the Texas-Mexico border, while railroad operators see impact. Read more here. 0

https://www.zacks.com/stock/news/2201050/wall-street-analysts-see-a-67-76-upside-in-exscientia-plc-sponsored-adr-exai-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2201050 Dec 21, 2023 - The consensus price target hints at a 67.8% upside potential for Exscientia PLC Sponsored ADR (EXAI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term. 0

https://seekingalpha.com/article/4658818-vug-large-cap-growth-easing-new-year?source=feed_tag_etf_portfolio_strategy Dec 20, 2023 - While growth has been a big winner in 2022, I see reasons for caution as we enter the new year. See why I downgrade VUG fund from buy to hold. 0

https://www.zacks.com/stock/news/2200084/s-p-500-etf-sees-historic-21b-influx-amid-stock-surge?cid=CS-ZC-FT-etf_news_and_commentary-2200084 Dec 19, 2023 - SPDR S&P 500 ETF Trust (SPY), which tracks the S&P 500 Index, pulled in a massive $20.8 billion in a single day, Dec 15, according to Bloomberg Intelligence 0

https://www.zacks.com/stock/news/2199980/wall-street-analysts-see-a-55-94-upside-in-baidu-inc-bidu-can-the-stock-really-move-this-high?cid=CS-ZC-FT-tale_of_the_tape|consensus_price_target-2199980 Dec 19, 2023 - The average of price targets set by Wall Street analysts indicates a potential upside of 55.9% in Baidu Inc. (BIDU). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock. 0

https://www.rttnews.com/story.aspx?Id=3412481 Dec 19, 2023 - After ending the previous session mostly higher, stocks are likely to see further upside in early trading on Tuesday. Optimism about the outlook for interest rates may contribute to continued strength on Wall Street, as stocks appear poised to extend the upward trend seen over the past several sessions. 0